◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT02808858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Italiana Sindromi Mielodisplastiche-ETS |
| Condition | Myelodysplastic-Myeloproliferative Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2013-09 |
| Primary Completion | 2016-06 |
Trial Parameters
Condition Myelodysplastic-Myeloproliferative Diseases
Sponsor Fondazione Italiana Sindromi Mielodisplastiche-ETS
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age 106 Years
Start Date 2013-09
Completion 2016-06
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.
Eligibility Criteria
Inclusion Criteria: * New diagnosis of MDS Exclusion Criteria: * Patient who refuse the signature of informed consent
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology